T h e v i d e o p l a y e d a t t h e m e e t i n g c a n b e v i e w e d o n t h e C o m p a n y ' s w e b s i t e
2021 AGM - CEO Presentation 1
K E Y A C H I E V E M E N T S F O R F Y 2 0 2 1
Micro-X laid out the infrastructure for future growth across all four products
ersonal use only
$3.6m of sales + establishment of multiple distributorships, non- exclusive paths to market
- Mobile DR range
Veterinary market launch and first
sale into Australia
- Mobile DR range
Micro-X Rover - US 510(k) and on Australian ARTG - higher margin and Micro-Xbranded
- Mobile DR range
'Argus' bomb detection on time and budget - strong police and military interest for 2022 launch
- X-ray camera
Rover Mark II high power
generator & tube tested with 4 times the output and same size
- Mobile DR range
Bolstered US sales, marketing and engineering activities with Seattle office
$8m non-dilutive funding with ASA
under MRFF programme
- Stroke CT scanner
Up to US$4.0m non-dilutive
funding from US Department of
Homeland Security
- Airport Security Checkpoints
Successful $34m capital raising -
now debt free
2021 AGM - CEO Presentation 2
O U R S T R A T E G Y
How we Plan to Monetise Our 'First Mover' Advantage
use only
OUR GOAL
Four production lines
common technology platforms
global sales volumes
•
no competitive alternative
Create required paths to
•
high-margin
market at scale
operating within five years
Expand channel
partners &
Early
Successful first movers in breakthrough
technology move quickly
commercial
Commercial success becomes a barrier
leadsrship
to entry for others
Platform
technology in hanging fruit
Look for low
collaborations
cold cathode x-ray
products
ersonal
Commercialise high in the value chain to
maximise revenue
avoid commoditisation as long as possible
keep innovating to stay in front of competitors
Commercialise
high in the value chain
Our technology delivers a customer benefit and the best product margins
2021 AGM - CEO Presentation 3
O N E C O M PA N Y - F O U R B U S I N E S S E S
Each unique product drives a new market-focused Business Unit
ersonal use only
Mobile DR
First Sales
2018
Addressable Market
US$500m pa*
Pre COVID-19 levels , Omdia Market Report Note: Dates are estimates and may vary
Cameras
Checkpoints
First Sales
First Sales
2022
2024
Addressable Market
Addressable Market
US$1.8b *
USA: US$8b *
RoW: US$16b *
* Estimate based on published numbers
* Estimate based on published TSA data,
of EOD Teams world-wide, potential
potential volume & price
volume & price
CT
First Sales
2026
Addressable Market
US$5b *
Estimate based on published numbers of Ambulances in USA & EUR, potential volume & price
2021 AGM - CEO Presentation 4
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Micro-X Ltd. published this content on 18 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 November 2021 22:02:05 UTC.
Micro-X Limited is an Australia-based company, which is engaged in developing and commercializing a range of products for global health and security markets, based on proprietary cold cathode, carbon nanotube (CNT) emitter technology. The electronic control of emitters with this technology enables X-ray products with a significant reduction in size, weight, and power requirements, enabling mobility and ease of use in existing X-ray markets and a range of new security and defense applications. The Companyâs products include mobile digital X-ray machines, intermittent explosive disorder (IED) X-ray cameras, miniature baggage scanners, and computed tomography (CT) brain scanners. Its commercial mobile digital radiology products are sold for diagnostic imaging in global healthcare, military, and veterinary applications. The Company is also focused on designing Airport Checkpoint Portal for the United States Department of Homeland Security.